Showing results (71-80 of 231) with videos related to
Sort By:
Pageof 24
Cardiovascular Diabetology|April 1, 2021
Report from the CVOT Summit 2020: new cardiovascular and renal outcomesOliver Schnell, Xavier Cos, Francesco Cosentino, et al.Heart (British Cardiac Society)|July 16, 2017
Glycaemic control and excess risk of major coronary events in persons with type 1 diabetesViktorija Matuleviciene-Anängen, Annika Rosengren, Ann-Marie Svensson, et al.Diabetes, Obesity & Metabolism|January 5, 2019
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative RegistryWenjun Fan, Yang Song, Silvio E Inzucchi, et al.Clinical Cardiology|June 1, 2016
The Association Between Complementary and Alternative Medicine and Health Status Following Acute Myocardial InfarctionAli Shafiq, Natalie Jayaram, Kensey L Gosch, et al.Journal of Diabetes and Its Complications|October 23, 2021
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbiditiesKamlesh Khunti, Hiddo J L Heerspink, Carolyn S P Lam, et al.The American Journal of Cardiology|July 26, 2011
Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomesAdam C Salisbury, Mikhail Kosiborod, Amit P Amin, et al.Circulation|February 6, 2014
Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarctionSuzanne V Arnold, Mikhail Kosiborod, Fengming Tang, et al.Journal of the American College of Cardiology|April 9, 2013
The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarctionSuzanne V Arnold, Kasia J Lipska, Yan Li, et al.Circulation. Heart Failure|May 28, 2019
Understanding Contemporary Use of ThiazolidinedionesSuzanne V Arnold, Silvio E Inzucchi, Justin B Echouffo-Tcheugui, et al.Circulation|December 28, 2018
Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes MellitusGiovane R Sousa, David Pober, Alfonso Galderisi, et al.Pageof 24